Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Spaarne Ziekenhuis

Hoofddorp, NetherlandsNot linked to an institution yet

2running trials
3closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial
NCT01558921· Phase 3· Source
Active, not recruiting
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
NCT01057069· Phase 2/3· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation
NCT02950051· Phase 3· Source
Completed
Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases
NCT02162563· Phase 3· Source
Completed
R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL
NCT01865110· Phase 3· Source

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error

Under construction, not live – Spaarne Ziekenhuis: trial site – Frontlight Research